Theranostics Health Presents TheraLink® Assay for Breast Cancer at Biomarker World Congress

 

 

Biomarker World Congress 2015
2:50 pm, Tuesday May 5, 2015
Loews Philadelphia Hotel
Philadelphia, PA

 

Glenn Hoke, Ph.D., Executive Vice President and COO, is providing a presentation on the TheraLink®Assay for Breast Cancer titled “A novel Phospho-Proteomic Diagnostic for Patient Stratification and Therapy Selection for Breast Cancer” at the Biomarker World Congress.